Elevance Health Inc (NYSE:ELV) currently has a daily average trading volume of 1.15M but it saw 1834776 shares traded in last market. With a market cap of 96.37B USD, the company’s current market price of $415.54 came falling about -1.02 while comparing to the previous closing price of $419.84. In past 52 weeks, the stock remained buoying in the range of price level as high as $567.26 and as low as $397.98. In the recent trading on the day, stock has struck highest price mark of $412.4103 while lowest mark touched by it was $420.59.
BofA Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on July 18, 2024 while assigning a price target range of $646-$530. Morgan Stanley issued its recommendations for the stock as it initiated the price target for the stock is $643.
Over the week, ELV’s stock price is moving -16.38% down while it is -21.20% when we observe its performance for the past one month. Year-to-date it is -11.88% down and over the past year, the stock is showing a downside performance of -8.02%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 5.62 beaten by the consensus estimate of 5.64 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of 3.8 while estimate for next year EPS is 32.96. In next quarter, company is expected to be making quarterly sales of $45.65B as analysts are expecting the sales for current fiscal year at $175.05B and seeing the company making $188.5B in sales next year. Moreover, analysts are in estimates of $44.73B for current-quarter revenue.
Currently, Elevance Health Inc’s total number of outstanding shares is 233.07M. Company’s return on investment (ROI) stands at 9.37% and return on equity (ROE) at 15.62%. It has a price to earnings ratio (P/E ratio) of 15.15 while having a 11.47 of forward P/E ratio. Stock’s beta reads 0.82. Stock has a price to book (P/B) ratio of 2.20 while price to sale or P/S ratio amounts to 0.55. Its return on asset (ROA) is 5.65% on average.
